Erik Sjögren
Forskare vid Institutionen för farmaceutisk biovetenskap; Forskning; Translationell läkemedelsutveckling
- Telefon:
- 018-471 41 54
- E-post:
- erik.sjogren@uu.se
- Besöksadress:
- BMC, Husargatan 3
75124 Uppsala - Postadress:
- Box 591
75124 Uppsala
Mer information visas för dig som medarbetare om du loggar in.
Kort presentation
Denna text finns inte på svenska, därför visas den engelska versionen.
Assoc. Prof. Erik Sjögren research focus is mechanistic and physiologically based modelling & simulation, i.e., physiologically based pharmacokinetic (PBPK), physiologically based biopharmaceutics modeling (PBBM) and quantitative system pharmacology (QSP), for predictions, translations and analyses of information and data across all phases in drug development.
Nyckelord
- biopharmaceutics
- drug delivery
- modeling and simulation
- pbbm
- pbpk
- pharmacokinetics
- physiologically based modeling
- qsp
Publikationer
Urval av publikationer
- Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project (2020)
- Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link (2019)
- Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences (2019)
- Mechanistic modelling of intestinal drug absorption (2018)
- In vivo Drug Delivery Performance of Lipiodol-based Emulsion or Drug-eluting Beads in Patients with Hepatocellular Carcinoma (2017)
- In Silico Modeling of Gastrointestinal Drug Absorption (2016)
- Direct In Vivo Human Intestinal Permeability (P-eff) Determined with Different Clinical Perfusion and Intubation Methods (2015)
- Human in Vivo Regional Intestinal Permeability (2015)
- In vivo methods for drug absorption - Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects (2014)
- In silico predictions of gastrointestinal drug absorption in pharmaceutical product development (2013)
Senaste publikationer
- Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling (2023)
- Physiologically based biopharmaceutics modeling of regional and colon absorption in humans (2023)
- Drug diffusion in biomimetic hydrogels (2022)
- Overview of authorized drug products for subcutaneous administration (2022)
- Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds - An overview of in silico models (2022)
Alla publikationer
Artiklar
- Understanding Statin-Roxadustat Drug–Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling (2023)
- Physiologically based biopharmaceutics modeling of regional and colon absorption in humans (2023)
- Drug diffusion in biomimetic hydrogels (2022)
- Overview of authorized drug products for subcutaneous administration (2022)
- Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds - An overview of in silico models (2022)
- Does the choice of applied physiologically-based pharmacokinetics platform matter? (2022)
- Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study (2022)
- In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes (2021)
- Six years of progress in the oral biopharmaceutics area - A summary from the IMI OrBiTo project (2020)
- Intestinal absorption of BCS class II drugs administered as nanoparticles (2020)
- Drug Absorption Parameters Obtained Using the Isolated Perfused Rat Lung Model Are Predictive of Rat In Vivo Lung Absorption (2020)
- Pulmonary drug absorption and systemic exposure in human (2020)
- Lipiodol-based emulsions used for transarterial chemoembolization and drug delivery (2019)
- Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model (2019)
- Rat intestinal drug permeability (2019)
- Liver Cancer Cell Lines Treated with Doxorubicin under Normoxia and Hypoxia (2019)
- Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model (2019)
- Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link (2019)
- Does the Intake of Ethanol Affect Oral Absorption of Poorly Soluble Drugs? (2019)
- Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical Sciences (2019)
- Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions (2019)
- The effect of intradermal microdosing of a transient receptor potential cation channel subfamily V member 1 antagonist on heat evoked pain and thermal thresholds in normal and ultraviolet-C exposed skin in healthy volunteers (2019)
- Single bead investigation of a clinical drug delivery system – a novel release mechanism (2018)
- The effects of three absorption-modifying critical excipients on the in vivo intestinal absorption of six model compounds in rats and dogs. (2018)
- Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport. (2018)
- Time-dependent effects on small intestinal transport by absorption-modifying excipients (2018)
- Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'" (2018)
- Porcine and Human In Vivo Simulations for Doxorubicin-Containing Formulations Used in Locoregional Hepatocellular Carcinoma Treatment (2018)
- Pulmonary absorption - estimation of effective pulmonary permeability and tissue retention of ten drugs using an ex vivo rat model and computational analysis (2018)
- Jejunal absorption of aprepitant from nanosuspensions (2018)
- Mechanistic modelling of intestinal drug absorption (2018)
- Preclinical characterization of three transient receptor potential vanilloid receptor 1 antagonists for early use in human intradermal microdose analgesic studies (2018)
- Clinical testing of three novel transient receptor potential cation channel subfamily V member 1 antagonists in a pharmacodynamic intradermal capsaicin model (2018)
- Applications of Clinically Relevant Dissolution Testing (2018)
- Preclinical Effect of Absorption Modifying Excipients on Rat Intestinal Transport of Model Compounds and the Mucosal Barrier Marker 51Cr-EDTA (2017)
- A Model -Based Approach To Assessing the Importance of Intracellular Binding Sites in Doxorubicin Disposition (2017)
- Computational fluid dynamics (CFD) studies of a miniaturized dissolution system (2017)
- In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation (2017)
- In vivo Drug Delivery Performance of Lipiodol-based Emulsion or Drug-eluting Beads in Patients with Hepatocellular Carcinoma (2017)
- Lipiodol does not affect the tissue distribution of intravenous doxorubicin infusion in pigs (2017)
- In Vivo Mechanisms of Intestinal Drug Absorption from Aprepitant Nanoformulations (2017)
- Regional Intestinal Permeability in Rats (2017)
- Reply to "Comment on 'In Silico Modeling of Gastrointestinal Drug Absorption (2017)
- In Vitro Release Mechanisms of Doxorubicin From a Clinical Bead Drug-Delivery System (2016)
- Regional Intestinal Permeability in Dogs (2016)
- Regional Intestinal Permeability of Three Model Drugs in Human (2016)
- Assessment of Free Drug Concentration in Cyclodextrin Formulations Is Essential to Determine Drug Potency in Functional In Vitro Assays (2016)
- Excised segments of rat small intestine in Ussing chamber studies (2016)
- In Silico Modeling of Gastrointestinal Drug Absorption (2016)
- A miniaturized in vitro release method for investigating drug-release mechanisms (2015)
- Direct In Vivo Human Intestinal Permeability (P-eff) Determined with Different Clinical Perfusion and Intubation Methods (2015)
- Concomitant intake of alcohol may increase the absorption of poorly soluble drugs (2015)
- Human in Vivo Regional Intestinal Permeability (2015)
- Combining in vitro and in silico methods for better prediction of surfactant effects on the absorption of poorly water soluble drugs-a fenofibrate case example (2014)
- Treatment of intermediate stage hepatocellular carcinoma (2014)
- The Effects of Lipiodol and Cyclosporin A on the Hepatobiliary Disposition of Doxorubicin in Pigs (2014)
- In vivo methods for drug absorption - Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects (2014)
- Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs (2014)
- Pharmacokinetics of an Injectable Modified-Release 2-Hydroxyflutamide Formulation in the Human Prostate Gland Using a Semiphysiologically Based Biopharmaceutical Model (2014)
- In silico predictions of gastrointestinal drug absorption in pharmaceutical product development (2013)
- The pharmacokinetics and hepatic disposition of repaglinide in pigs (2012)
- Optimized Experimental Design for the Estimation of Enzyme Kinetic Parameters (2012)
- Binding processes determine the stereoselective intestinal and hepatic extraction of verapamil in vivo (2012)
- Optimal experimental design for assessment of enzyme kinetics in a drug discovery screening environment (2011)
- Hepatic disposition of ximelagatran and its metabolites in pig; prediction of the impact of membrane transporters through a simple disposition model (2010)
- Online capillary solid phase extraction and liquid chromatographic separation with quantitative tandem mass spectrometric detection (SPE-LC-MS/MS) of ximelagatran and its metabolites in a complex matrix. (2009)
- The multiple depletion curves method provides accurate estimates of intrinsic clearance (CLint), maximum velocity of the metabolic reaction (Vmax), and Michaelis constant (Km) (2009)
- Quantitative imaging of doxorubicin diffusion and cellular uptake in biomimetic gels with human liver tumor cells
- Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population
- Physiologically Based Pharmacokinetics Modeling and Transporter Proteomics to Predict Systemic and Local Liver and Muscle Disposition of Statins
- Effects of absorption-modifying excipients on jejunal drug absorption in simulated fasted and fed luminal conditions